{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:48Z","timestamp":1786119408859,"version":"build-2736575974"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1097\/mca.0b013e3282f3fbcb","type":"journal-article","created":{"date-parts":[[2010,2,25]],"date-time":"2010-02-25T01:45:01Z","timestamp":1267062301000},"page":"133-137","source":"Crossref","is-referenced-by-count":12,"title":["Th2-dependent cytokine release in patients treated with coronary angioplasty"],"prefix":"10.1097","volume":"19","author":[{"given":"Natale Daniele","family":"Brunetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martino","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Munno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Tiecco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Quagliara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"De Gennaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gaglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Di Biase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Favale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210204","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0021-9150(03)00012-1","article-title":"Circulating markers of inflammation and atherosclerosis","volume":"169","author":"Lind","year":"2003","journal-title":"Atherosclerosis"},{"key":"R3-2-20210204","first-page":"951","article-title":"Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis","volume":"138","author":"Moyer","year":"1991","journal-title":"Am J Pathol"},{"key":"R4-2-20210204","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0021-9150(99)00013-1","article-title":"Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease","volume":"145","author":"Fiotti","year":"1999","journal-title":"Atherosclerosis"},{"key":"R5-2-20210204","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0021-9150(94)05503-B","article-title":"Interleukin-1 beta induces expression of adhesion molecules in human vascular smooth muscle cells and enhances adhesion of leukocytes to smooth muscle cells","volume":"115","author":"Wang","year":"1995","journal-title":"Atherosclerosis"},{"key":"R6-2-20210204","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0021-9150(99)00241-5","article-title":"Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis","volume":"148","author":"Gawaz","year":"2000","journal-title":"Atherosclerosis"},{"key":"R7-2-20210204","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/01.hjh.0000226198.44181.0c","article-title":"Interleukin 6 is associated with subclinical atherosclerosis: a link with soluble intercellular adhesion molecule 1","volume":"24","author":"Amar","year":"2006","journal-title":"J Hypertens"},{"key":"R8-2-20210204","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1172\/JCI118476","article-title":"Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor","volume":"97","author":"Shimokawa","year":"1996","journal-title":"J Clin Invest"},{"key":"R9-2-20210204","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0021-9150(96)05968-0","article-title":"Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall","volume":"127","author":"Rus","year":"1996","journal-title":"Atherosclerosis"},{"key":"R10-2-20210204","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.CIR.94.5.874","article-title":"Elevated levels of IL-6 in unstable angina","volume":"94","author":"Biasucci","year":"1996","journal-title":"Circulation"},{"key":"R11-2-20210204","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1161\/01.CIR.99.16.2079","article-title":"Increasing levels of interleukin (IL)-1Ra and IL-6 during the first two days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events","volume":"99","author":"Biasucci","year":"1999","journal-title":"Circulation"},{"key":"R12-2-20210204","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1018758409934","article-title":"Circulating levels of IL-1beta, a prothrombotic cytokine, are elevated in unstable angina vs. stable angina","volume":"9","author":"Simon","year":"2000","journal-title":"J Thromb Thrombolysis"},{"key":"R13-2-20210204","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0002-9149(02)03097-7","article-title":"Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris","volume":"91","author":"Yamashita","year":"2003","journal-title":"Am J Cardiol"},{"key":"R15-2-20210204","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1053\/hj.1998.v136.90408","article-title":"Inflammatory profile in unstable angina vs. stable angina in patients undergoing percutaneous interventions","volume":"136","author":"Yazdani","year":"1998","journal-title":"Am Heart J"},{"key":"R16-2-20210204","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/01.ATV.16.8.1000","article-title":"Interleukin-1 \u03b2 in coronary arteries of patients with ischemic heart disease","volume":"16","author":"Galea","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R17-2-20210204","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/jmcc.2000.1278","article-title":"IL-4-induced oxidative stress upregulates VCAM-1 gene expression in human endothelial cells","volume":"33","author":"Lee","year":"2001","journal-title":"J Mol Cell Cardiol"},{"key":"R18-2-20210204","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.cardiores.2005.01.008","article-title":"Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice","volume":"66","author":"Merhi-Soussi","year":"2005","journal-title":"Cardiovasc Res"},{"key":"R19-2-20210204","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1161\/hc3201.094973","article-title":"Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina","volume":"104","author":"Smith","year":"2001","journal-title":"Circulation"},{"key":"R20-2-20210204","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1046\/j.1365-2362.2002.01069.x","article-title":"Inflammatory imbalance between IL-10 and TNF-\u03b1 in unstable angina potential plaque stabilizing effects of IL-10","volume":"32","author":"Waehre","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"R22-2-20210204","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-3083.2006.01816.x","article-title":"TH1\/TH2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines \u2013 immunological alterations in acute coronary syndrome and stable coronary artery disease","volume":"64","author":"Szodoray","year":"2006","journal-title":"Scand J Immunol"},{"key":"R23-2-20210204","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/01.RES.0000021397.28936.F9","article-title":"T lymphocytes in atherosclerosis: the yin-yang of Th1 and Th2 influence on lesion formation","volume":"90","author":"Daugherty","year":"2002","journal-title":"Circ Res"},{"key":"R24-2-20210204","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0163-7258(02)00220-6","article-title":"Interleukins-4, -5, and -13: emerging therapeutic targets in allergic disease","volume":"94","author":"Foster","year":"2002","journal-title":"Pharmacol Ther"},{"key":"R25-2-20210204","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/383787a0","article-title":"Functional diversity of helper T lymphocytes","volume":"383","author":"Abbas","year":"1996","journal-title":"Nature"},{"key":"R26-2-20210204","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1067\/mai.2001.114989","article-title":"The other side of the coin: the protective role of the TH2 cytokines","volume":"107","author":"Finkelman","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"R27-2-20210204","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0091-6749(98)70080-6","article-title":"The role of IL-13 and its receptor in allergy and inflammatory responses","volume":"102","author":"de Vries","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"R28-2-20210204","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0952-7915(99)00025-4","article-title":"IL-13 in allergy: home at last","volume":"11","author":"Corry","year":"1999","journal-title":"Curr Opin Immunol"},{"key":"R29-2-20210204","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1182\/blood.V76.7.1392.1392","article-title":"Interleukin-4 (IL-4) inhibits secretion of IL-1\u03b2, tumor necrosis factor-\u03b1 and IL-6 by human monocytes","volume":"76","author":"Te Velde","year":"1990","journal-title":"Blood"},{"key":"R30-2-20210204","doi-asserted-by":"crossref","first-page":"9558","DOI":"10.1074\/jbc.270.16.9558","article-title":"Interleukin (IL)-10 inhibits nuclear factor \u03baB (NF-\u03baB) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms","volume":"270","author":"Wang","year":"1995","journal-title":"J Biol Chem"},{"key":"R31-2-20210204","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.4049\/jimmunol.151.11.6370","article-title":"Effects of IL-13 on phenotype, cytokine production, and cytokine function and cytotoxic function of human monocytes","volume":"151","author":"De Waal Malefyt","year":"1993","journal-title":"J Immunol"},{"key":"R32-2-20210204","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.4049\/jimmunol.148.4.1086","article-title":"IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: association with expression of VCAM-1","volume":"148","author":"Schleimer","year":"1992","journal-title":"J Immunol"},{"key":"R33-2-20210204","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1182\/blood.V87.10.4286.bloodjournal87104286","article-title":"Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain","volume":"87","author":"Schnyder","year":"1996","journal-title":"Blood"},{"key":"R34-2-20210204","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1172\/JCI741","article-title":"Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma","volume":"101","author":"Doucet","year":"1998","journal-title":"J Clin Invest"},{"key":"R35-2-20210204","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1380-2933(97)10005-7","article-title":"The TH1\/TH2 paradigm in allergy","volume":"3","author":"Maggi","year":"1998","journal-title":"Immunotechnology"},{"key":"R36-2-20210204","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4049\/jimmunol.160.1.60","article-title":"IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy","volume":"160","author":"Mochizuki","year":"1998","journal-title":"J Immunol"},{"key":"R37-2-20210204","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.4049\/jimmunol.165.10.5839","article-title":"Murine eotaxin-2: a constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression","volume":"165","author":"Zimmermann","year":"2000","journal-title":"J Immunol"},{"key":"R38-2-20210204","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.4049\/jimmunol.166.7.4507","article-title":"STAT6 mediates eotaxin-1 expression in IL-4 or TNF-alpha-induced fibroblasts","volume":"166","author":"Hoeck","year":"2001","journal-title":"J Immunol"},{"key":"R39-2-20210204","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.amjcard.2006.04.034","article-title":"Impact of percutaneous coronary intervention on the levels of interleukin-6 and C-reactive protein in the coronary circulation of subjects with coronary artery disease","volume":"98","author":"Ramadan","year":"2006","journal-title":"Am J Cardiol"},{"key":"R41-2-20210204","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.amjcard.2004.11.027","article-title":"Comparison of C-reactive protein levels after coronary stenting with bare metal vs. sirolimus-eluting stents","volume":"95","author":"de la Torre-Hernandez","year":"2005","journal-title":"Am J Cardiol"},{"key":"R42-2-20210204","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.atherosclerosis.2005.02.002","article-title":"Interleukin-18: Interleukin-10 ratio and in-hospital adverse events in patients with acute coronary syndrome","volume":"182","author":"Chalikias","year":"2005","journal-title":"Atherosclerosis"},{"key":"R43-2-20210204","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/hc3401.095074","article-title":"Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention","volume":"104","author":"Chew","year":"2001","journal-title":"Circulation"},{"key":"R44-2-20210204","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijcard.2003.12.027","article-title":"Role of endogenous interleukin-10 production and lipid peroxidation in patients with acute myocardial infarction treated with primary percutaneous transluminal coronary angioplasty, interleukin-10 and primary angioplasty","volume":"99","author":"Dominguez-Rodriguez","year":"2005","journal-title":"Int J Cardiol"},{"key":"R45-2-20210204","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00011-005-1342-0","article-title":"Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis \u2013 comparison with stable and unstable angina","volume":"54","author":"Kozinski","year":"2005","journal-title":"Inflamm Res"},{"key":"R46-2-20210204","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/01.CIR.100.8.793","article-title":"Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin","volume":"100","author":"Ikonomidis","year":"1999","journal-title":"Circulation"},{"key":"R47-2-20210204","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1046\/j.1365-2141.1996.d01-1731.x","article-title":"Downregulation of fibrinogen biosynthesis by IL-4, IL-10 and IL-13","volume":"93","author":"Vasse","year":"1996","journal-title":"Br J Haematol"},{"key":"R48-2-20210204","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1253\/circj.68.367","article-title":"Coronary spastic angina in patients with connective tissue disease","volume":"68","author":"Soejima","year":"2004","journal-title":"Circ J"},{"key":"R49-2-20210204","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.gene.6364225","article-title":"Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease","volume":"6","author":"Burns","year":"2005","journal-title":"Genes Immun"},{"key":"R51-2-20210204","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0014-5793(00)02208-0","article-title":"IL-4 induces apoptosis of endothelial cells through the caspase-3-dependent pathway","volume":"485","author":"Lee","year":"2000","journal-title":"FEBS Lett"},{"key":"R52-2-20210204","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/01.CIR.104.2.163","article-title":"Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization","volume":"104","author":"Lincoff","year":"2001","journal-title":"Circulation"},{"key":"R53-2-20210204","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.jacc.2005.12.084","article-title":"Effect of clopidogrel with and without eptifibatide on tumor necrosis factor-alpha and C-reactive protein release after elective stenting: results from the Clear Platelets 1b study","volume":"48","author":"Gurbel","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R54-2-20210204","doi-asserted-by":"crossref","first-page":"7777","DOI":"10.1073\/pnas.0508492103","article-title":"Simvastatin promotes Th2-type responses through the induction of the chitinase family member Ym1 in dendritic cells","volume":"103","author":"Arora","year":"2006","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MCA.0b013e3282f3fbcb","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:10:34Z","timestamp":1786039834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00019501-200805000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0b013e3282f3fbcb","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}